- recruitingPHASE2
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
This study looks at whether people with myeloma can safely give themselves their bortezomib chemotherapy injections at home, or have a caregiver do it. This could make treatment easier by reducing hospital visits.
Canada - not yet recruiting
REal World MAIA UK OutcomEs
This study looks at how a specific myeloma treatment called DRd (daratumumab, lenalidomide, and dexamethasone) is working for patients in the UK. Researchers want to see how well it's helping people with newly diagnosed myeloma who can't have a stem cell transplant, especially with how doctors adjust the doses.
United Kingdom - active not recruitingNA
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
This study is testing a new, easier way to give a drug called isatuximab (currently given through a drip) for people newly diagnosed with multiple myeloma who can't have a stem cell transplant. It aims to see if giving it as an injection under the skin works as well and is as safe.
France - not yet recruitingNA
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
This study looks at whether checking and treating dental problems before chemotherapy for blood cancers can reduce side effects like mouth sores and infections. It aims to see if this dental care plan, called PRIOR, is safe and can work in hospitals.
United Kingdom